Morning glory-derived anticancer agents, and novel ipomoeassin compounds

dc.contributor.assignee	Virginia Tech Intellectual Properties, Inc.	en
dc.contributor.inventor	Kingston, David G. I.	en
dc.contributor.inventor	Cao, Shugeng	en
dc.date.accessed	2016-08-19	en
dc.date.accessioned	2016-08-24T17:54:51Z	en
dc.date.available	2016-08-24T17:54:51Z	en
dc.date.filed	2006-03-03	en
dc.date.issued	2009-07-14	en
dc.description.abstract	Ipomoeassin compounds derived from morning glory plant material (especially Ipomoea sp. from Suriname) are useful as anti-cancer agents. The novel compounds also are useful for treating neurodegenerative disorders (such as Alzheimer's disease) in human patients.	en
dc.format.mimetype	application/pdf	en
dc.identifier.applicationnumber	11366806	en
dc.identifier.patentnumber	7560536	en
dc.identifier.uri	http://hdl.handle.net/10919/72604	en
dc.identifier.url	http://pimg-fpiw.uspto.gov/fdd/36/605/075/0.pdf	en
dc.language.iso	en_US	en
dc.publisher	United States Patent and Trademark Office	en
dc.subject.cpc	C07H13/02	en
dc.subject.uspc	536/6.5	en
dc.title	Morning glory-derived anticancer agents, and novel ipomoeassin compounds	en
dc.type	Patent	en
dc.type.dcmitype	Text	en
dc.type.patenttype	utility	en

Files

Now showing 1 - 1 of 1